Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (171-180 of 938) with videos related to

Pageof 94
Sort By:
Neuro-Oncology|September 18, 2012
Surgery for primary CNS lymphoma? Challenging a paradigmMichael Weller, Peter Martus, Patrick Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2020
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?Mustafa Khasraw, David A Reardon, Michael Weller, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
Advances in the molecular genetics of gliomas - implications for classification and therapyGuido Reifenberger, Hans-Georg Wirsching, Christiane B Knobbe-Thomsen, et al.
Journal of Neuropathology and Experimental Neurology|June 28, 2005
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivoJörg Wischhusen, Manuel A Friese, Michel Mittelbronn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 16, 2007
Radicular and nonradicular back pain in Parkinson's disease: a controlled studyDoris Broetz, Martin Eichner, Thomas Gasser, et al.
Cancer Research|December 10, 2017
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in GlioblastomaTobias Weiss, Michael Weller, Matthias Guckenberger, et al.
Expert Review of Neurotherapeutics|September 2, 2008
Therapy of X-linked adrenoleukodystrophyAlexander Semmler, Wolfgang Köhler, Hans H Jung, et al.
Cancer Treatment Reviews|September 26, 2013
Immunological challenges for peptide-based immunotherapy in glioblastomaMalte Mohme, Marian C Neidert, Luca Regli, et al.
Oncology Reports|March 22, 2008
The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell linesFriederike Schmidt, Christiane B Knobbe, Brigitte Frank, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 17, 2009
The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smokingAlexander Semmler, Susanna Moskau, Birgit Stoffel-Wagner, et al.
Pageof 94

Showing results (171-180 of 938) with videos related to

Sort By:
Pageof 94
Neuro-Oncology|September 18, 2012
Surgery for primary CNS lymphoma? Challenging a paradigmMichael Weller, Peter Martus, Patrick Roth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2020
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?Mustafa Khasraw, David A Reardon, Michael Weller, et al.
Nature Reviews. Clinical Oncology|December 30, 2016
Advances in the molecular genetics of gliomas - implications for classification and therapyGuido Reifenberger, Hans-Georg Wirsching, Christiane B Knobbe-Thomsen, et al.
Journal of Neuropathology and Experimental Neurology|June 28, 2005
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivoJörg Wischhusen, Manuel A Friese, Michel Mittelbronn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 16, 2007
Radicular and nonradicular back pain in Parkinson's disease: a controlled studyDoris Broetz, Martin Eichner, Thomas Gasser, et al.
Cancer Research|December 10, 2017
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in GlioblastomaTobias Weiss, Michael Weller, Matthias Guckenberger, et al.
Expert Review of Neurotherapeutics|September 2, 2008
Therapy of X-linked adrenoleukodystrophyAlexander Semmler, Wolfgang Köhler, Hans H Jung, et al.
Cancer Treatment Reviews|September 26, 2013
Immunological challenges for peptide-based immunotherapy in glioblastomaMalte Mohme, Marian C Neidert, Luca Regli, et al.
Oncology Reports|March 22, 2008
The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell linesFriederike Schmidt, Christiane B Knobbe, Brigitte Frank, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 17, 2009
The effect of MTHFR c.677C>T on plasma homocysteine levels depends on health, age and smokingAlexander Semmler, Susanna Moskau, Birgit Stoffel-Wagner, et al.
Pageof 94